Paul A. Overbeek, Ignacio García-Tuñón, Ziva Ben-Neriah, Reiner A. Veitia, Daniel Vaiman, Elena Llano, José Luis Barbero, Marc Fellous, Sandrine Caburet, Alberto M. Pendás, Valerie A. Arboleda, Eric Vilain, Wilbur Harrison, Kazuhiro Oka, Université Paris Diderot, Ligue Nationale contre le Cancer (France), Centre National de la Recherche Scientifique (France), Institut des Maladies Rares (France), National Institutes of Health (US), University of California, Ministerio de Economía y Competitividad (España), Junta de Castilla y León, Institut Jacques Monod (IJM), Université Paris Diderot - Paris 7 (UPD7) - Centre National de la Recherche Scientifique (CNRS), Department of Human Genetics, David Geffen School of Medicine, University of California at Los Angeles [Los Angeles] (UCLA), Departamento de Fisiología y Farmacología, Universidad de Salamanca, Instituto de Biología Molecular y Celular del Cáncer, Department of Molecular Cellular Biology, Baylor College of Medicine, Centro de Investigaciones Biológicas (CSIC), Consejo Superior de Investigaciones Científicas [Spain] (CSIC), Institut Cochin (UM3 (UMR 8104 / U1016)), Université Paris Descartes - Paris 5 (UPD5) - Institut National de la Santé et de la Recherche Médicale (INSERM) - Centre National de la Recherche Scientifique (CNRS), Department of Genetics, Hadassah University Hospital, Hadassah University Hospital, University Paris Diderot-Paris 7, Ligue Nationale contre le Cancer, Centre National de la Recherche Scientifique, GIS (Groupement d'Intérêt Scientifique), Institut des Maladies Rares, Doris Duke Charitable Foundation, National Institute of Child Health and Human Development (NICHD) (RO1HD068138 and R01HD044513), the NICHD (F31HD068136), UCLA Medical Scientist Training Program, Ministerio de Economía y Competitividad (SAF2011-25252), lentiviral mutagenesis studies were supported by the Ocular Development Fund, Institut Jacques Monod (IJM (UMR_7592)), Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), David Geffen School of Medicine [Los Angeles], University of California [Los Angeles] (UCLA), University of California-University of California, Baylor College of Medicine (BCM), Baylor University-Baylor University, Institut Cochin (IC UM3 (UMR 8104 / U1016)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Consejo Superior de Investigaciones Científicas [Madrid] (CSIC), and Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
7 p.- 2 fig.-- et al., Premature ovarian failure is a major cause of female infertility. The genetic causes of this disorder remain unknown in most patients. Using whole-exome sequence analysis of a large consanguineous family with inherited premature ovarian failure, we identified a homozygous 1-bp deletion inducing a frameshift mutation in STAG3 on chromosome 7. STAG3 encodes a meiosis-specific subunit of the cohesin ring, which ensures correct sister chromatid cohesion. Female mice devoid of Stag3 are sterile, and their fetal oocytes are arrested at early prophase I, leading to oocyte depletion at 1 week of age., Supported by grants from the University Paris Diderot-Paris 7(to Drs. Caburet, Veitia, and Fellous), the Ligue Nationale contre le Cancer and the Centre National de la Recherche Scientifique (to Drs. Caburet and Veitia), the GIS (Groupement d’Intérêt Scientifique) Institut des Maladies Rares (to Drs. Caburet and Fellous), the Doris Duke Charitable Foundation and National Institute of Child Health and Human Development (NICHD) (RO1HD068138 and R01HD044513, to Drs. Arboleda and Vilain), the NICHD (F31HD068136) and the UCLA Medical Scientist Training Program (both to Dr. Arboleda), and the Ministerio de Economía y Competitividad (SAF2011-25252) and Junta de Castilla y León (both to Drs. Llano and Pendás). The lentiviral mutagenesis studies were supported by the Ocular Development Fund (to Dr. Overbeek).